Cambrex hits engineering milestone

Cambrex has completed initial engineering studies for its new, large-scale API plant in Charles City, Iowa. Groundbreaking is scheduled to take place in late 2026. The company said that this milestone “marks significant progress toward the company's previously announced $120 million investment in expanding its US API manufacturing capabilities”.  

The expansion will add 20% to the site’s large-scale manufacturing capacity via a new plant with 140 m3 of capacity, including large- and mid-scale reactors, advanced Hastelloy agitated filter-dryers and enhancements to existing suites. It is also designed to support complex chemistry, including controlled substances, HPAPIs and commercial-scale liquid phase peptide manufacturing.